Pseudomonas aeruginosa and Acinetobacter species in particular are most often associated with carbapenem resistance. This is of significance since NFGNB can cause fatal, LRTIS in patients admitted to ICU. 14 Carbapenem resistance appears to be due to metallo-β-Lactamases and this can be transferred to other species like Escherichia coli, Enterobacter spp. and Klebsiella spp. posing serious problem 15 due to lack of therapeutic options. Chromosomal Ampc β-Lactamases can slowly hydrolyze imipenem. When expression of an Ampc enzyme is coupled with an additional mechanism of resistance, frank carbapenem resistance can result. The combination of porin loss and class c β-lactamase expression is an important cause of imipenem resistance in P. aeruginosa 16 and Acinetobacter baumanii. (Table 3) . Antimicrobial resistance pattern of pseudomonas isolates, reference to imipenem and meropenem (Table 4) . Antimicrobial resistant pattern of Acinitobacter showing resistance to carbapenems (Table  5) . Among the 38 Pseudomonas isolated 16 (42%) were resistant to imipenem and 11(29%) were resistant to meropenem (Table 6 ). 14(28%) and 12 (24%) of Acinetobacter spp. showed resistance to imipenem and meropenem respectively ( Table 7) . 14 reported 36.4% of non fermentors were resistant to imipenem and Navneeth et al. 7 reported a prevalence of 12% carbapenem resistance among 50 strains of Pseudomonas aeruginosa isolated from various clinical specimens spp. carbapenem resistance in Acinetobacter spp is an emerging problem and is a cause of concern as many nosocomial Acinetobacters are detected to be resistant to most other antibiotics. Taneja et al.
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METHODS
14 reported a high incidence of more than 20% carbapenem resistance among Acinetobacters. Corbella et al. found a high incidence (36%) of carbapenem resistance in Acinetobacter spp. among ICU patients 19 and Manikal et al. observed 50% carbapenem resistance among Acinetobacters in a New York hospital. 20 Although there are specific tests to detect the underlying mechanism of Carbapenem resistance, Kirby Bauer disc diffusion test is a simple, easy to perform and cost effective test which can be conveniently used to screen carbapenem resistance. We found lesser incidence of resistance to meropenem than imipenem which is welltolerated and offers several potential advantages, including greater in vitro activity against gram-negative pathogens and the option of bolus administration.
CONCLUSION
As our study documented an increase in carbapenem resistance unwarranted and unrestricted usage of antibiotics is associated with emergence of resistance in common nosocomial pathogens like Acinetobacter spp. Reduction in antimicrobial resistance in the ICUS has been a goal for all ICUS as it improves outcome and cost to the patients in terms of the expenses for costly antibiotics as well as prolonged ICU study. Measures to reduce antibiotic resistance include evidence-based selection of antibiotics, shorter courses of appropriately selected antibiotics with adequate dosages, surveillance for resistant organisms, cyclical usage of new antibiotics, education of consumers and prescribers about use and misuse of antibiotics or by potential use of probiotics. Steps need to be taken to prevent antimicrobial resistance or else this emerging menace would erode the strength of life-saving antibiotics, leave them with the negligible effect of placebo and put all significant resources allocated to research and treatment to waste in already resource poor countries.
